What's The BUZZ?

Market News, Products, Services, and Trends

ANiGENT is Named a 2025 Pharmacy500 Company!

The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the previous year. These select 500 represent companies that are shaping the pharmacy landscape, driving operational excellence, and supporting exemplary patient care.


For the full list, selection criteria, and details, please visit www.rxinsider.com/Pharmacy500.


ANiGENT

ANiGENT News & Announcements

ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refinements in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce actionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements. To learn more about ANiGENT and MAAP Analytics, visit ANiGENT.com.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from ANiGENT is Named a 2025 Pharmacy500 Company!

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe